搜尋結果
2017年2月20日 · 郭﹕抗血栓藥分兩種，抗血小板藥和抗凝血藥。抗血小板藥包括阿士匹靈（aspirin）及氯比格雷（clopidogrel）；而常見的抗凝血藥有華法林及新型口服抗凝血藥物。兩種抗血栓藥有何分別？
Compare Aspirin vs Plavix head-to-head with other drugs for uses, ratings, cost, side effects and interactions.
Aspirin and Plavix (clopidogrel) are drugs that prevent blood clots to reduce the risk of heart attacks and strokes, or subsequent heart attacks and strokes. Aspirin and Plavix can be taken together; however, taking them together increases the risk of gastrointestinal (GI) bleeding.
6 天前 · 主要結果. 結果顯示clopidogrel合併使用aspirin對降低心臟病發作或中風風險是有好處的。 然而，其發生主要出血和次要出血的風險較高。 此研究並無因心臟問題死亡或其他任何原因 導致死亡。 證據品質. 依考科藍標準，有四篇試驗是低偏差風險。 依GRADE標準而言，多數結果的出版證據品質是中等的，但是因任何原因造成死亡的結果是低等的、副作用的結果證據是極低等的。 如果您發現此證據有幫助，請考慮向 Cochrane 捐款。 我們是一家慈善機構，提供可獲取的證據來幫助人們做出健康和照護之決定。 捐贈. 翻譯紀錄:
The CAPRIE study, which directly compared the risks of cardiovascular events (stroke, AMI, and vascular death) between clopidogrel and aspirin through a randomized blinded trial, found that the risk of the composite measure for cardiovascular events was 14 14
2018年5月16日 · In patients with minor ischemic stroke or high-risk TIA, those who received a combination of clopidogrel and aspirin had a lower risk of major ischemic events but a higher risk of major...
2018年9月28日 · Clopidogrel was thought to be superior to aspirin for secondary prevention of vascular diseases in clinical trials. In this study we assessed the safety and efficacy of clopidogrel versus aspirin in real‐world practice by using the Taiwan Stroke Registry. Methods and Results.
- www.ncbi.nlm.nih.gov
- › …
- › Cardiovasc Ther
- › v.2019; 2019
2019年12月1日 · Published trial data suggests clopidogrel as single antiplatelet therapy is safe and effective for secondary prevention compared to aspirin and the combination of aspirin/dipyridamole [27, 29].
2024年8月29日 · An analysis of clopidogrel versus aspirin was not conducted for major bleeding, although no significant difference was seen between aspirin and monotherapy with any P2Y12i for the risk of major bleeding (RR: 1.12; 95% CI: 0.82, 1.53). The findings reported in
2018年12月18日 · This guideline was triggered by a randomised controlled trial that compared dual antiplatelet therapy (DAPT, clopidogrel plus aspirin) with aspirin monotherapy given within 12-24 hours of symptom onset in patients with high-risk transient ischaemic attack or minor
